Skip to main content

Table 1 The Scottish Intercollegiate Guidelines Network (SIGN) grading system 1999–2012

From: Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review

Level of evidence

Study design and methodological quality

Level 1++

High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias

Level 1+

Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias

Level 1−

Meta-analyses, systematic reviews, or RCTs with a high risk of bias

Level 2++

High quality systematic reviews of case control or cohort studies

High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal

Level 2+

Well-conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal

Level 2−

Case control or cohort studies with a high risk of confounding or bias and a significant risk that the relationship is not causal

Level 3

Non-analytic studies, e.g. case reports, case series

Level 4

Expert opinion

  1. Level of evidence by study design and methodological quality of interventional studies using the SIGN system. RCT, randomized controlled trials